用心肌细胞丰富的USP20通过准STAT3脱化来改善病态心脏缩
Lingfeng Zhong1,2,3, Shanshan Dai4, Fan Yu1,2,3
1Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|April 7, 2025
概括
脱乌比基化酶-特定于乌比基的蛋白酶20 (USP20) 通过调节信号转换器和转录3 (STAT3) 激活器来保护心脏缩. 缺少USP20会使心脏膨胀恶化,而过度表达会减轻心脏膨胀,从而揭示出治疗目标.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 病理性心脏缩是心力衰竭的主要原因.
- 驱动心脏缩的精确分子机制尚未完全理解.
- 脱化酶 (DUBs) 在细胞过程中起着关键作用,但它们在心脏缩中的参与需要进一步调查.
研究的目的:
- 在心脏缩中研究DUB泛基因特异蛋白酶20 (USP20) 的作用和机制.
- 在心肌细胞中识别USP20基质和下游点.
- 探索USP20途径在缓解心脏缩方面的治疗潜力.
主要方法:
- 超性心脏的转录形状分析,以识别改变的DUB表达.
- 同免疫沉 (Co-IP) 和液体染色学-并联质谱学 (LC-MS/MS) 用于识别USP20基质.
- 目标下断层和分类 (CUT&Tag) 测序以识别STAT3下游目标.
- 心脏缩的体内模型 (Angiotensin II和TAC) 和药理抑制 (统计).
主要成果:
- USP20表达在过度缩的心脏中显著下调,主要存在于心肌细胞中.
- USP20缺乏会加剧心脏缩,而USP20过度表达会减轻心脏缩.
- USP20二基化STAT3,减少其酸化和核转位,从而抑制STAT3在CARM1促进体中的转录活性.
- 这导致CARM1表达升调和缓解过度缩,STAT3被证实是关键的调解者.
结论:
- 在心肌细胞中发现了一种新的USP20/STAT3/CARM1信号轴.
- 通过调节STAT3活性,USP20对心脏缩起着保护作用.
- 针对USP20/STAT3/CARM1通路具有治疗心脏缩和心力衰竭的治疗潜力.
相关概念视频
The JAK-STAT Signaling Pathway
8.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K


